Although CD47 is widely expressed on the surface of a broad range of cell types, high levels of CD47 have also been observed in haematological cancers such as acute myeloid leukaemia (AML), ALL, CLL, multiple myeloma (MM), myelodysplastic syndrome (MDS), DLBCL, MCL, and MZL [174,177,178,179,180,181,182]. Here, CD47 is linked to plasma cell myeloma.